Literature DB >> 24494809

What do infectious diseases physicians do? A 2-week snapshot of inpatient consultative activities across Australia, New Zealand and Singapore.

P R Ingram1, A C Cheng, R J Murray, C C Blyth, T Walls, D A Fisher, J S Davis.   

Abstract

The practice of an infectious diseases (ID) physician is evolving. A contemporary understanding of the frequency and variety of patients and syndromes seen by ID services has implications for training, service development and setting research priorities. We performed a 2-week prospective survey of formal ID physician activities related to direct inpatient care, encompassing 53 hospitals throughout Australia, New Zealand and Singapore, and documented 1722 inpatient interactions. Infections involving the skin and soft tissue, respiratory tract and bone/joints together accounted for 49% of all consultations. Suspected/confirmed pathogens were primarily bacterial (60%), rather than viral (6%), fungal (4%), mycobacterial (2%) or parasitic (1%). Staphylococcus aureus was implicated in 409 (24%) episodes, approximately four times more frequently than the next most common pathogen. The frequency of healthcare-related infections (35%), immunosuppression (21%), diabetes mellitus (19%), prosthesis-related infections (13%), multiresistant pathogens (13%) and non-infectious diagnoses (9%) was high, although consultation characteristics varied between geographical settings and hospital types. Our study highlights the diversity of inpatient-related ID activities and should direct future teaching and research. ID physicians' ability to offer beneficial consultative advice requires broad understanding of, and ability to interact with, a wide range of referring specialities.
© 2014 The Authors Clinical Microbiology and Infection © 2014 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Keywords:  Australia; New Zealand; Singapore; consultations; infectious diseases

Mesh:

Year:  2014        PMID: 24494809     DOI: 10.1111/1469-0691.12581

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  6 in total

1.  The value of specialist care-infectious disease specialist referrals-why and for whom? A retrospective cohort study in a French tertiary hospital.

Authors:  M Sasikumar; S Boyer; A Remacle-Bonnet; B Ventelou; P Brouqui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-17       Impact factor: 3.267

2.  A comparison of paediatric and adult infectious diseases consultations in Australia and New Zealand.

Authors:  C C Blyth; T Walls; A C Cheng; R J Murray; D A Fisher; P R Ingram; J S Davis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-04-29       Impact factor: 3.267

3.  Infectious disease services: a survey from four university hospitals in Germany.

Authors:  Siegbert Rieg; Florian Hitzenbichler; Stefan Hagel; Isabelle Suarez; Florian Kron; Bernd Salzberger; Mathias Pletz; Winfried V Kern; Gerd Fätkenheuer; Norma Jung
Journal:  Infection       Date:  2018-08-17       Impact factor: 3.553

4.  Managing diabetic foot infections: a survey of Australasian infectious diseases clinicians.

Authors:  Robert J Commons; Edward Raby; Eugene Athan; Hasan Bhally; Sharon Chen; Stephen Guy; Paul R Ingram; Katy Lai; Chris Lemoh; Lyn-Li Lim; Laurens Manning; Spiros Miyakis; Mary O'Reilly; Adam Roberts; Marjoree Sehu; Adrienne Torda; Mauro Vicaretti; Peter A Lazzarini
Journal:  J Foot Ankle Res       Date:  2018-04-10       Impact factor: 2.303

5.  Infection characteristics and treatment of Staphylococcus aureus bacteraemia at a tertiary children's hospital.

Authors:  Alasdair P S Munro; Christopher C Blyth; Anita J Campbell; Asha C Bowen
Journal:  BMC Infect Dis       Date:  2018-08-10       Impact factor: 3.090

6.  Timeliness of Infectious Diseases Referral and Inappropriate Antibiotic Usage Post-Referral in an Asian Tertiary Hospital.

Authors:  Liang En Wee; Aidan Lyanzhiang Tan; Limin Wijaya; Maciej Piotr Chlebicki; Julian Thumboo; Ban Hock Tan
Journal:  Trop Med Infect Dis       Date:  2019-11-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.